When a company pays graded amount of dividend on annualized basis and its reserves also find increase successively, it implies that the stock is poised for good times provided it is given reasonable time when invested into. Lupin is one such stock in pharma sector.
A totally debt free company with equity capital of around 89 core and increasing reserves (each year) - currently at 8937 crore and enhanced rate of dividend, it sales and net profit for Dec 2015 were on the higher side (contrary to majority of the Indian companies putting up a dismal show). At an average profit generating efficiency level of around 24% and it being not only a growth oriented company equally caring for the interests of its share holders, it is a buy at the currently quoted 52 week quoted price.
Those who can give time to this stock, should zero - in on this for decent yield.